HensonFuerst Investigating Questionable Cancer Treatment Trials at Duke University Medical Center
North Carolina patients exposed to dangerous medical conditions after participating in discredited cancer treatments based on flawed research
Raleigh, NC (PRWEB) January 12, 2011
North Carolina law firm HensonFuerst Attorneys is launching an investigation after the latest news reports concerning faulty cancer research conducted by Dr. Anil Potti at Duke University Medical Center. The law firm is actively seeking information from people who underwent breast cancer and lung cancer treatments based on Potti’s now-discredited research.
As reported by The News & Observer, at least 110 cancer patients were enrolled in three clinical trials based on flawed research of Dr. Potti, a now discredited Duke associate professor who resigned in November after his work and embellished credentials came under scrutiny. According to patient claims, these treatments did nothing to stop tumor growth and even led to blood clots and other serious medical complications. In fact, Dr. Michael Cuffe, Duke’s vice president for medical affairs stated the medical trials should not have been done based on the problems with Potti’s research.
“Even though questions about Dr. Potti, were raised more than three years ago, all three trials apparently continued and patients may have received ineffective or potentially dangerous treatments,” Raleigh attorney David Henson said. “We’re trying to find out why these trials continued and what impact they had on patients.”
According to The News & Observer, Duke missed opportunities to take quick action once Potti’s research was questioned more than three years ago, and the clinical trials were allowed to continue despite serious concerns. Researchers from other institutions related their issues communicating with Duke officials about Potti’s research. Biostatisticians at MD Anderson Cancer Center in Texas first voiced their concerns in 2007, but it was not until 2009 that Duke stopped the trials. Apparently, Duke officials decided to restart the trials in January 2010, only to stop once again in July 2010. Unfortunately, patients at Duke may have received ineffective or potentially dangerous treatments.
“Our civil justice system, while the best in the world, sometimes is least fair to injured persons,” Henson said. “Our goal as lawyers who represent injured persons is to make sure that all important facts are discovered so our clients and the public can make the best health decisions possible. Those decisions should be made on fact, however, and not spin or hype.”
This is not the first time HensonFuerst has helped patients who have been affected by Duke University’s lack of concern for patient safety. In 2004, more than 3,500 patients learned their surgical procedures were performed using instruments that had been washed with used elevator hydraulic fluid instead of detergent. The patients were left with unanswered questions, unresolved fears of complications, and, for some, a lifetime of pain and disability linked to the tainted instruments. At the time, Duke officials promised to do more to safeguard the safety of its patients.
The professionals at HensonFuerst represented many of these patients and understand how large medical centers can deny wrongdoing and tell patients their health has not been compromised, even when the facts seem to suggest otherwise.
Patients, medical professionals, and anyone else related to Dr. Potti’s clinical trials are encouraged to contact attorney David Henson at (919) 781-1107.
HensonFuerst, P.A., is a North Carolina-based law firm specializing in catastrophic injury, nursing home abuse, medical malpractice, and mass tort cases. For more than 30 years, the lawyers at HensonFuerst have represented those injured by the negligence of others. With successful multimillion-dollar verdicts and settlements throughout the state of North Carolina, the team of 11 lawyers and 30 staff members at HensonFuerst offer considerable experience and resources for their clients. For more information about the firm, visit http://www.HensonFuerst.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebduke-medical-center/anil-potti-cancer-trial/prweb4961014.htm